https://www.marketscreener.com/quote/stock/SAREPTA-THERAPEUTICS-INC-11204214/news/Sarepta-to-Seek-Accelerated-FDA-OK-of-SRP-9001-in-Duchenne-Muscular-Dystrophy-41133139/?utm_source=telegram&utm_medium=social&utm_campaign=share